Gian Life Care IPO is a Fixed Price listing on BSE SME exchange. The company is based in Kanpur and caters to Healthcare sector. Hem Securities is the merchant banker of Gian Life Care IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 5th July 2019.
Gian Life Care IPO posted revenues of ₹ 7.28 crores and PAT of ₹ 1.36 crores in FY20 on annualised basis.Financial results of Gian Life Care IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Financials | Jun-19 | FY19 | |||
---|---|---|---|---|---|
Balance Sheet
|
|||||
Assets | 7.97 | 7.82 | |||
Net Worth | 3.70 | 0.08 | |||
Total Debt | 0.91 | 0.98 | |||
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
1.79
7.16 |
0.56 | |||
EBITDA
EBITDA on annualised basis |
0.58
2.32 |
0.14 | |||
PAT
PAT on annualised basis |
0.34
1.36 |
0.07 |
Gian Life Care IPO PAT Margin is 18.99 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Gian Life Care IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
Particulars | Jun-19 | FY19 |
---|---|---|
EBITDA Margin (%) | 32.40 | 25.00 |
PAT Margin (%) | 18.99 | 12.50 |
EPS (₹) | 1.03 | 0.21 |
ROE (%) | 9.19 | 87.50 |
ROCE (%) | [●] | [●] |
ROA (%) | 4.27 | 0.90 |
Debt to Equity | 0.25 | 12.25 |
The market Capitalisation of Gian Life Care IPO is ₹ 10.34 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Gian Life Care IPO prospectus highlights an Return on Equity (ROE) of 15 %, Return on Assets (ROA) of 12 %, and an EBITDA Margin of 18 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Gian Life Care IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Gian Life Care IPO is ₹ 10.34 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Gian Life Care IPO has a Price-to-Earnings (PE) ratio of 7.61 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Gian Life Care IPO reported revenue of ₹ 7.28 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Gian Life Care IPO provide insights into sales growth, market demand, and business scalability.
Gian Life Care recorded an EBITDA of ₹ 2.32 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Gian Life Care Profit After Tax (PAT) is ₹ 1.36 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Gian Life Care operates in Healthcare and Healthcare Service Provider. The Issue is listed on BSE SME in Jan, 2020. Gian Life Care IPO size was 3.12 with Issue price of 22.00 .
Merchant Banker(s) of Gian Life Care IPO: Hem Securities Limited
Gian Life Care IPO subscription was 1.34 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Gian Life Care IPO listed at a listing price of 22.00 against the offer price of 22.00.
The current market price of Gian Life Care is 16.18.
Why Us?